🇺🇸 FDA
Patent

US 9138437

Pyrimidine substituted purine compounds as kinase (S) inhibitors

granted A61KA61K31/5377A61P

Quick answer

US patent 9138437 (Pyrimidine substituted purine compounds as kinase (S) inhibitors) held by VERASTEM, INC. expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VERASTEM, INC.
Grant date
Tue Sep 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/5377, A61P, A61P1/00, A61P1/04